Skip to main content alibris logo

Biosimilars and Interchangeable Biologics: Strategic Elements

by

Write The First Customer Review
Biosimilars and Interchangeable Biologics: Strategic Elements - Niazi, Sarfaraz K.
Filter Results
Item Condition
Seller Rating
Other Options
Change Currency

What's the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets ...

loading
Biosimilars and Interchangeable Biologics: Strategic Elements 2017, CRC Press, London

ISBN-13: 9781138775503

Paperback

Biosimilars and Interchangeable Biologics: Strategic Elements 2015, CRC Press Inc, Bosa Roca

ISBN-13: 9781498743471

Hardcover